Blog
- All
- California
- Commentary
- Guidelines
- Indications
- Methods
- News
- Pharmacy
- Policy
- Reference
- Research
- Training
- Uncategorized
Putting Policy into Practice: Contraception Care in San Francisco Pharmacies
What makes some pharmacies more successful than others at implementing pharmacist-prescribed contraception care? To answer this question, we conducted a study to determine the extent of hormonal contraceptive prescribing, also referred to as furnishing in California, among San Francisco community pharmacies, and identify the factors that led to successful implementation.
Reducing Maternal Mortality in the United States through Collaboration
New training program by Birth Control Pharmacist and Provide includes pharmacy best practices to combat stigma and communication guides and online resources to help connect patients with local resources.
New Webinar Prepares Pharmacists to Provide Reproductive Health Services and Referrals
New training program by Birth Control Pharmacist and Provide includes pharmacy best practices to combat stigma and communication guides and online resources to help connect patients with local resources.
Meet Phexxi – A New Non-Hormonal Contraceptive Gel
About the Product Lactic acid, citric acid, and potassium bitartrate (Phexxi, Evofem Biosciences) is a prescription combination, non-hormonal contraceptive gel approved by the FDA in May 2020. The vaginal gel…
Can Contraceptives be Vegan? Important Considerations for Vegan Patients
The Vegan Society defines veganism as “a way of living which seeks to exclude, as far as is possible and practicable, all forms of exploitation of, and cruelty to, animals…
Measuring Blood Pressure: An Important Prerequisite to Prescribing Hormonal Contraception
Why is it important to measure blood pressure before prescribing hormonal contraception? Combined hormonal contraceptives (CHCs) are a relatively safe and effective method for your patients in preventing pregnancy and…
Effectiveness of Hormonal Contraceptives in Patients with Higher Weights
Introduction Obesity is becoming more prevalent every year and as pharmacists, it is important to revisit current contraceptive options for these patients. Overweight patients are defined as having a BMI…
No Taxation for Menstruation: The Importance of Student Pharmacist Advocates
At the University of Michigan College of Pharmacy, the APhA-ASP chapter’s inaugural Women’s Health Campaign hosted multiple events to educate and engage student pharmacists and the Ann Arbor community. While…
Finding Gluten-Free Oral Contraceptive Options for Your Patients
Patients with celiac disease or who otherwise follow a gluten-free diet need to be aware of potential sources of gluten, especially in medications such as oral contraceptives. The FDA defines…
Updates in Male Contraceptive Agents
Male contraceptive agents have been highly anticipated as the next step in contraception innovation. To date, several hormonal agents have been developed and tested for safety and efficacy, with three…
Contraception During COVID-19: Pharmacy Best Practices
Pharmacists should not allow postponed or cancelled appointments to keep patients from accessing birth control. It’s important that patients understand how their pharmacy can continue to meet their contraceptive needs…
Clinical Considerations for Contraception During COVID: Extended Duration of IUDs and Implants
During the COVID-19 pandemic and beyond, patients may desire a contactless method of contraception. The subcutaneous (SQ) formulation of depot medroxyprogesterone acetate (DMPA), Depo-SubQ Provera, is an important option to offer patients. This may be of particular interest among patients who currently come in to the pharmacy or go to a clinic for their intramuscular (IM) injection.
5 Pearls from the 2020 States Forum on Pharmacist Birth Control Services
The second annual States Forum on Pharmacist Birth Control Services recently was held by the Birth Control Pharmacist project in partnership with the National Alliance of State Pharmacy Associations (NASPA).…
Contraception During COVID: California’s Medi-Cal and FamilyPACT Programs Cover Depo-SubQ Provera
We recently wrote about the importance of offering patients subcutaneous depot medroxyprogesterone acetate (DMPA-SQ) as a contactless form of contraception during the COVID-19 public health emergency. California pharmacists can prescribe…
Clinical Considerations for Contraception During COVID: Patient Self-Administration
During the COVID-19 pandemic and beyond, patients may desire a contactless method of contraception. The subcutaneous (SQ) formulation of depot medroxyprogesterone acetate (DMPA), Depo-SubQ Provera, is an important option to offer patients. This may be of particular interest among patients who currently come in to the pharmacy or go to a clinic for their intramuscular (IM) injection.
2020 CDC Update for Contraceptive Use in Women at High Risk for HIV
The CDC published updated guidelines to the 2016 U.S. Medical Eligibility Criteria for Contraceptive Use regarding women at high risk for HIV infection in April 2020.
Contraception for Your Transgender Patients
Terminology Navigating through a discussion about gender and sexuality with the many terms used today can be confusing. Here is a brief introduction to terminology regarding the multifaceted gender spectrum.1…
Twirla: A New Contraceptive Patch
Twirla is a new contraceptive patch that was approved by the FDA earlier this month on February 14, 2020.
Endometriosis Basics and How Contraception Can Help
What is endometriosis? Endometriosis is characterized as a condition in which endometrial tissue, which normally lines the uterus, develops outside of the uterine cavity in abnormal locations such as the…
Should We Offer Preconception Services in Community Pharmacies?
Why is preconception care important? Roughly 4 million pregnancies occur in the United States annually.1 A common misconception is that preconception care is only a health care need when there…
Teratogenic Medications and Contraception Management
The use of prescription medications by pregnant women has increased over the past 30 years and with the usage comes an increased associated risk of exposing the fetus to the…
- « Previous
- 1
- 2
- 3
- 4
- Next »